New insights into cardiovascular and lipid metabolomics

Journal of Cellular Biochemistry

Volumn 105, Issue 3, 2008, Pages 648-654

  Giovane, Alfonso ^a   Balestrieri, Antonio ^a   Napoli, Claudio ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Cardiovascular diseases; Lipids; Metabolomics

Indexed keywords

CAPILLARY ELECTROPHORESIS; CARDIOVASCULAR DISEASE; GAS CHROMATOGRAPHY; GLYCOLYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIPID METABOLISM; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; METABOLOMICS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTEIN METABOLISM; PROTEOMICS; PROTON NUCLEAR MAGNETIC RESONANCE; REVIEW; URINALYSIS;

CARDIOVASCULAR DISEASES; HUMANS; LIPID METABOLISM; METABOLOMICS;

EID: 54849439476     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.21875     Document Type: Review

References (63)

1. Albert CJ, Anbukumar DS, Monda JK, Eckelkamp JT, Ford DA. 2007. Myocardial lipidomics. Developments in myocardial nuclear lipidomics. Front Biosci 12:2750-2760.
2. Andreadou I, Iliodromitis EK, Mikros E, Bofilis E, Zoga A, Constantinou M, Tsantili-Kakoulidou A, Kremastinos DT. 2004. Melatonin does not prevent the protection of ischemic preconditioning in vivo despite its antioxidant effect against oxidative stress. Free Radic Biol Med 37(4):500-510.
3. Aranibar N, Ott KH, Roongta V, Mueller L. 2006. Metabolomic analysis using optimized NMR and statistical methods. Anal Biochem 355(1):62-70.
4. Balestrieri ML, Giovane A, Mancini FP, Napoli C. 2008. Proteomics and cardiovascular disease: An update. Curr Med Chem 15:555-572.
5. Bays HE, Gonzalez-Campoy JM, Bray GA, Kitabchi AE, Bergman DA, Schorr AB, Rodbard HW, Henry RR. 2008. Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity. Expert Rev Cardiovasc Ther 6(3):343-368.
6. Betz M, Saxena K, Schwalbe H. 2006. Biomolecular NMR: A chaperone to drug discovery. Curr Opin Chem Biol 10(3):219-225.
7. Birkemeyer C, Luedemann A, Wagner C, Erban A, Kopka J. 2005. Metabolome analysis: The potential of in vivo labeling with stable isotopes for metabolite profiling. Trends Biotechnol 23(1):28-33.
8. Boernsen KO, Gatzek S, Imbert G. 2005. Controlled protein precipitation in combination with chip-based nanospray infusion mass spectrometry. An approach for metabolomics profiling of plasma. Anal Chem 77(22):7255-7264.
9. Brindle JT, Antti H, Holmes E, Tranter G, Nicholson JK, Bethell HW, Clarke S, Schofield PM, McKilligin E, Mosedale DE, Grainger DJ. 2002. Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics. Nat Med 8(12):1439-1444.
10. Constantinou MA, Tsantili-Kakoulidou A, Andreadou I, Iliodromitis EK, Kremastinos DT, Mikros E. 2007a. Application of NMR-based metabonomics in the investigation of myocardial ischemia-reperfusion, ischemic preconditioning and antioxidant intervention in rabbits. Eur J Pharm Sci 30(3-4):303-314.
11. Constantinou MA, Vertzoni M, Reppas C, Tsantili-Kakoulidou A, Mikros E. 2007b. 1H NMR monitoring of the canine metabolic profile after oral administration of xenobiotics using multivariate statistics. Mol Pharm 4(2):258-268.
12. Cornett DS, Reyzer ML, Chaurand P, Caprioli RM. 2007. MALDI imaging mass spectrometry: Molecular snapshots of biochemical systems. Nat Methods 4(10):828-833.
13. de Boer IH, Astor BC, Kramer H, Palmas W, Rudser K, Seliger SL, Shlipak MG, Siscovick DS, Tsai MY, Kestenbaum B. 2008. Mild elevations of urine albumin excretion are associated with atherogenic lipoprotein abnormalities in the Multi-Ethnic Study of Atherosclerosis (MESA). Atherosclerosis 197(1):407-414.
14. Dix DJ, Houck KA, Martin MT, Richard AM, Setzer RW, Kavlock RJ. 2007. The ToxCast program for prioritizing toxicity testing of environmental chemicals. Toxicol Sci 95(1):5-12.
15. Drexler DM, Garrett TJ, Cantone JL, Diters RW, Mitroka JG, Prieto Conaway MC, Adams SP, Yost RA, Sanders M. 2007. Utility of imaging mass spectrometry (IMS) by matrix-assisted laser desorption ionization (MALDI) on an ion trap mass spectrometer in the analysis of drugs and metabolites in biological tissues. J Pharmacol Toxicol Methods 55(3):279-288.
16. Fiehn O, Kristal B, van Ommen B, Sumner LW, Sansone SA, Taylor C, Hardy N, Kaddurah-Daouk R. 2006. Establishing reporting standards for metabolomic and metabonomic studies: A call for participation. OMICS 10(2):158-163.
17. German JB, Gillies LA, Smilowitz JT, Zivkovic AM, Watkins SM. 2007. Lipidomics and lipid profiling in metabolomics. Curr Opin Lipidol 18(1):66-71.
18. Glisic S, Arrigo P, Alavantic D, Perovic V, Prljic J, Veljkovic N. 2008. Lipoprotein lipase: A bioinformatics criterion for assessment of mutations as a risk factor for cardiovascular disease. Proteins 70(3):855-862.
19. Griffin JL, Nicholls AW. 2006. Metabolomics as a functional genomic tool for understanding lipid dysfunction in diabetes, obesity and related disorders. Pharmacogenomics 7(7):1095-1107.
20. Han X, Abendschein DR, Kelley JG, Gross RW. 2000. Diabetes-induced changes in specific lipid molecular species in rat myocardium. Biochem J 352(Pt 1):79-89.
21. Han X, Gross RW. 2005a. Shotgun lipidomics: Electrospray ionization mass spectrometric analysis and quantitation of cellular lipidomes directly from crude extracts of biological samples. Mass Spectrom Rev 24(3):367-412.
22. Han X, Gross RW. 2005b. Shotgun lipidomics: Multidimensional MS analysis of cellular lipidomes. Expert Rev Proteomics 2(2):253-264.
23. Han X, Holtzman DM, McKeel DW Jr. 2001. Plasmalogen deficiency in early Alzheimer's disease subjects and in animal models: Molecular characterization using electrospray ionization mass spectrometry. J Neurochem 77(4):1168-1180.
24. Han X, Holtzman M, McKeel DW Jr, Kelley J, Morris JC. 2002. Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer's disease: Potential role in disease pathogenesis. J Neurochem 82(4):809-818.
25. Han X, Yang J, Cheng H, Yang K, Abendschein DR, Gross RW. 2005. Shotgun lipidomics identifies cardiolipin depletion in diabetic myocardium linking altered substrate utilization with mitochondrial dysfunction. Biochemistry 44(50):16684-16694.
26. Han X, Yang J, Yang K, Zhao Z, Abendschein DR, Gross RW. 2007. Alterations in myocardial cardiolipin content and composition occur at the very earliest stages of diabetes: A shotgun lipidomics study. Biochemistry 46(21):6417-6428.
27. Iakoubova OA, Tong CH, Rowland CM, Kirchgessner TG, Young BA, Arellano AR, Shiffman D, Sabatine MS, Campos H, Packard CJ, Pfeffer MA, White TJ, Braunwald E, Shepherd J, Devlin JJ, Sacks FM. 2008a. Association of the Trp719Arg polymorphism in kinesin-like protein 6 with myocardial infarction and coronary heart disease in 2 prospective trials: The CARE and WOSCOPS trials. J Am Coll Cardiol 51(4):435-443.
28. Iakoubova OA, Sabatine MS, Rowland CM, Tong CH, Catanese JJ, Ranade K, Simonsen KL, Kirchgessner TG, Cannon CP, Devlin JJ, Braunwald E. 2008b. Polymorphism in KIF6 gene and benefit from statins after acute coronary syndromes: Results from the PROVE IT-TIMI 22 study. J Am Coll Cardiol 51(4):449-455.
29. Jackson SN, Ugarov M, Egan T, Post JD, Langlais D, Albert SJ, Woods AS. 2007. MALDI-ion mobility-TOFMS imaging of lipids in rat brain tissue. J Mass Spectrom 42(8):1093-1098.
30. Katajamaa M, Oresic M. 2007. Data processing for mass spectrometry-based metabolomics. J Chromatogr A 1158(1-2):318-328.
31. Kemsley EK, Le Gall G, Dainty JR, Watson AD, Harvey LJ, Tapp HS, Colquhoun IJ. 2007. Multivariate techniques and their application in nutrition: A metabolomics case study. Br J Nutr 98(1):1-14.
32. Kind T, Tolstikov V, Fiehn O, Weiss RH. 2007. A comprehensive urinary metabolomic approach for identifying kidney cancer. Anal Biochem 363(2):185-195.
33. Kola B, Grossman AB, Korbonits M. 2008. The role of AMP-activated protein kinase in obesity. Front Horm Res 36:198-211.
34. Kristal BS, Shurubor YI, Kaddurah-Daouk R, Matson WR. 2007. High-performance liquid chromatography separations coupled with coulometric electrode array detectors: A unique approach to metabolomics. Methods Mol Biol 358:159-174.
35. Kusano M, Fukushima A, Kobayashi M, Hayashi N, Jonsson P, Moritz T, Ebana K, Saito K. 2007. Application of a metabolomic method combining one-dimensional and two-dimensional gas chromatography-time-of-flight/mass spectrometry to metabolic phenotyping of natural variants in rice. J Chromatogr B Analyt Technol Biomed Life Sci 855(1):71-79.
36. Liguori A, Abete P, Hayden JM, Cacciatore F, Rengo F, Ambrosio G, Bonaduce D, Condorelli M, Reaven PD, Napoli C. 2001. Effect of glycaemic control and age on low-density lipoprotein susceptibility to oxidation in diabetes mellitus type 1. Eur Heart J 22(22):2075-2084.
37. Markley JL, Anderson ME, Cui Q, Eghbalnia HR, Lewis IA, Hegeman AD, Li J, Schulte CF, Sussman MR, Westler WM, Ulrich EL, Zolnai Z. 2007. New bioinformatics resources for metabolomics. Pac Symp Biocomput Proc 157-168.
38. Materi W, Wishart DS. 2007. Computational systems biology in drug discovery and development: Methods and applications. Drug Discov Today 12(7-8):295-303.
39. McLean JA, Ridenour WB, Caprioli RM. 2007. Profiling and imaging of tissues by imaging ion mobility-mass spectrometry. J Mass Spectrom 42(8):1099-1105.
40. Miller DT, Ridker PM, Libby P, Kwiatkowski DJ. 2007. Atherosclerosis: The path from genomics to therapeutics. J Am Coll Cardiol 49(15):1589-1599.
41. Monton MR, Soga T. 2007. Metabolome analysis by capillary electrophoresis-mass spectrometry. J Chromatogr A 1168(1-2):237-246.
42. Nishikawa Y, Dmochowska B, Madaj J, Xue J, Guo Z, Satake M, Reddy DV, Rinaldi PL, Monnier VM. 2003. Vitamin C metabolomic mapping in experimental diabetes with 6-deoxy-6-fluoro-ascorbic acid and high resolution 19F-nuclear magnetic resonance spectroscopy. Metabolism 52(6):760-770.
43. Pan Z, Raftery D. 2007. Comparing and combining NMR spectroscopy and mass spectrometry in metabolomics. Anal Bioanal Chem 387(2):525-527.
44. Reyzer ML, Caprioli RM. 2007. MALDI-MS-based imaging of small molecules and proteins in tissues. Curr Opin Chem Biol 11(1):29-35.
45. Sabatine MS, Liu E, Morrow DA, Heller E, McCarroll R, Wiegand R, Berriz GF, Roth FP, Gerszten RE. 2005. Metabolomic identification of novel biomarkers of myocardial ischemia. Circulation 112(25):3868-3875.
46. Salek RM, Maguire ML, Bentley E, Rubtsov DV, Hough T, Cheeseman M, Nunez D, Sweatman BC, Haselden JN, Cox RD, Connor SC, Griffin JL. 2007. A metabolomic comparison of urinary changes in type 2 diabetes in mouse, rat, and human. Physiol Genomics 29(2):99-108.
47. Shen Y, Zhang R, Moore RJ, Kim J, Metz TO, Hixson KK, Zhao R, Livesay EA, Udseth HR, Smith RD. 2005. Automated 20 kpsi RPLC-MS and MS/MS with chromatographic peak capacities of 1000-1500and capabilities in proteomics and metabolomics. Anal Chem 77(10):3090-3100.
48. Shiffman D, Chasman DI, Zee RY, Iakoubova OA, Louie JZ, Devlin JJ, Ridker PM. 2008. A kinesin family member 6 variant is associated with coronary heart disease in the Women's Health Study. J Am Coll Cardiol 51(4):444-448.
49. Smit S, van Breemen MJ, Hoefsloot HC, Smilde AK, Aerts JM, de Koster CG. 2007. Assessing the statistical validity of proteomics based biomarkers. Anal Chim Acta 592(2):210-217.
50. Soga T. 2007. Capillary electrophoresis-mass spectrometry for metabolomics. Methods Mol Biol 358:129-137.
51. Styczynski MP, Moxley JF, Tong LV, Walther JL, Jensen KL, Stephanopoulos GN. 2007. Systematic identification of conserved metabolites in GC/MS data for metabolomics and biomarker discovery. Anal Chem 79(3):966-973.
52. Summers LK. 2006. Adipose tissue metabolism, diabetes and vascular disease-Lessons from in vivo studies. Diab Vasc Dis Res 3(1):12-21.
53. Sun G, Yang K, Zhao Z, Guan S, Han X, Gross RW. 2007. Shotgun metabolomics approach for the analysis of negatively charged water-soluble cellular metabolites from mouse heart tissue. Anal Chem 79(17):6629-6640.
54. Tsai MY, Johnson C, Kao WH, Sharrett AR, Arends VL, Kronmal R, Jenny NS, Jacobs DR Jr, Arnett D, O'Leary D, Post W. 2008. Cholesteryl ester transfer protein genetic polymorphisms, HDL cholesterol, and subclinical cardiovascular disease in the Multi-Ethnic Study of Atherosclerosis. Atherosclerosis (in press).
55. Ulrich EL, Akutsu H, Doreleijers JF, Harano Y, Ioannidis YE, Lin J, Livny M, Mading S, Maziuk D, Miller Z, Nakatani E, Schulte CF, Tolmie DE, Kent WR, Yao H, Markley JL. 2008. BioMagResBank. Nucleic Acids Res 36(Database issue):D402-D408.
56. Vaidyanathan S, Goodacre R. 2007. Quantitative detection of metabolites using matrix-assisted laser desorption/ionization mass spectrometry with 9-aminoacridine as the matrix. Rapid Commun Mass Spectrom 21(13):2072-2078.
57. van der GJ, Martin S, Juhasz P, Adourian A, Plasterer T, Verheij ER, McBurney RN. 2007. The art and practice of systems biology in medicine: Mapping patterns of relationships. J Proteome Res 6(4):1540-1559.
58. Walsh MC, Brennan L, Malthouse JP, Roche HM, Gibney MJ. 2006. Effect of acute dietary standardization on the urinary, plasma, and salivary metabolomic profiles of healthy humans. Am J Clin Nutr 84(3):531-539.
59. Want EJ, Nordstrom A, Morita H, Siuzdak G. 2007. From exogenous to endogenous: The inevitable imprint of mass spectrometry in metabolomics. J Proteome Res 6(2):459-468.
60. Watson AD. 2006. Thematic review series: Systems biology approaches to metabolic and cardiovascular disorders. Lipidomics: A global approach to lipid analysis in biological systems. J Lipid Res 47(10):2101-2111.
61. Weckwerth W. 2003. Metabolomics in systems biology. Annu Rev Plant Biol 54:669-689.
62. Wishart DS, Tzur D, Knox C, Eisner R, Guo AC, Young N, Cheng D, Jewell K, Arndt D, Sawhney S, Fung C, Nikolai L, Lewis M, Coutouly MA, Forsythe I, Tang P, Shrivastava S, Jeroncic K, Stothard P, Amegbey G, Block D, Hau DD, Wagner J, Miniaci J, Clements M, Gebremedhin M, Guo N, Zhang Y, Duggan GE, Macinnis GD, Weljie AM, Dowlatabadi R, Bamforth F, Clive D, Greiner R, Li L, Marrie T, Sykes BD, Vogel HJ, Querengesser L. 2007. HMDB: The Human Metabolome Database. Nucleic Acids Res 35(Database issue):D521-D526.
63. Zhao G, Jeoung NH, Burgess SC, Rosaaen-Stowe KA, Inagaki T, Latif S, Shelton JM, McAnally J, Bassel-Duby R, Harris RA, Richardson JA, Kliewer SA. 2008. Overexpression of pyruvate dehydrogenase kinase 4 in heart perturbs metabolism and exacerbates calcineurin-induced cardiomyopathy. Am J Physiol Heart Circ Physiol 294(2):H936-H943.